GeneQuine Biotherapeutics
Hamburg
About GeneQuine Biotherapeutics
GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Feb 2021)
- Website: genequine.comde
- Phone: 49 40 766 29 28 51
Industries & Categories
Biopharma, Biotechnology, Developer Tools, Health Care
Social Profiles
Canonical: https://fsome.com/organization/genequine-biotherapeutics-68168 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.